Calculate Kt/V dialysis adequacy using the Daugirdas II formula. Includes spKt/V, eKt/V, URR, stdKt/V, Watson body water, and adequacy troubleshooting.
The Kt/V Calculator measures hemodialysis adequacy — the single most important quantitative assessment of whether a dialysis patient is receiving enough treatment to maintain health. Using the Daugirdas II second-generation formula (the international standard), this tool calculates single-pool Kt/V (spKt/V), equilibrated Kt/V (eKt/V), urea reduction ratio (URR), and standardized weekly Kt/V (stdKt/V) from pre- and post-dialysis blood urea nitrogen measurements.
Kt/V represents the ratio of dialyzer urea clearance (K) times treatment time (t) divided by the volume of distribution of urea (V, approximately total body water). KDOQI guidelines recommend a minimum spKt/V of 1.2 per session for thrice-weekly hemodialysis, with a target of 1.4 for optimal outcomes. Studies consistently show that patients receiving adequate dialysis have lower mortality, fewer hospitalizations, better nutrition, and improved quality of life.
This calculator also estimates total body water using the Watson formula, computes ultrafiltration volume and rate, provides evidence-based troubleshooting for inadequate clearance, and generates clinical recommendations based on your results. It supports comparison between different dialysis schedules through the standardized weekly Kt/V metric — essential for evaluating daily, nocturnal, and peritoneal dialysis regimens.
Monitoring Kt/V is mandatory at every dialysis center — it is the primary CMS quality metric for dialysis adequacy. Regular measurement identifies underdialysis before clinical deterioration occurs and guides prescription adjustments to optimize patient outcomes. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain. Use this clarification to avoid ambiguous interpretation.
Daugirdas II: spKt/V = −ln(R − 0.008×t) + (4 − 3.5R) × UF/W, where R = post-BUN/pre-BUN, t = hours, UF = ultrafiltration (kg), W = post-weight (kg). eKt/V = spKt/V − 0.6(spKt/V)/t + 0.03. URR = (1 − R) × 100%.
Result: spKt/V = 1.45, eKt/V = 1.25, URR = 68.6%
R = 22/70 = 0.314. UF = 2.5 kg. spKt/V = −ln(0.314 − 0.008×4) + (4 − 3.5×0.314) × 2.5/72.5 = 1.45. This exceeds the KDOQI target of 1.2, indicating excellent dialysis adequacy.
Before Kt/V, dialysis adequacy was assessed subjectively — if patients felt okay, treatment was deemed sufficient. The National Cooperative Dialysis Study (NCDS, 1981) was the first randomized trial to show that higher urea clearance improved outcomes, and Frank Gotch's reanalysis introduced the Kt/V concept. The HEMO Study (2002) refined our understanding, showing that a minimum spKt/V of 1.2 was necessary but that increasing beyond 1.6 did not significantly reduce mortality.
John Daugirdas developed the second-generation Kt/V formula in 1993 to address limitations of the original Gotch formula, particularly accounting for ultrafiltration volume and urea generation during dialysis. This formula is now the international standard used by virtually every dialysis center.
While Kt/V measures small-molecule clearance (urea, MW 60 Da), uremic toxins span a wide molecular weight range. Middle molecules like beta-2-microglobulin (MW 11,800) and protein-bound toxins like indoxyl sulfate are poorly cleared by conventional hemodialysis and require longer treatment times, high-flux membranes, or alternative modalities.
Extended dialysis time (4-5 hours TIW or more frequent sessions) improves outcomes independent of Kt/V through: better phosphate clearance, improved hemodynamic stability (lower UF rates), enhanced middle-molecule removal, and smoother fluid removal. The Frequent Hemodialysis Network trial demonstrated that daily short or nocturnal hemodialysis improved markers of health even at similar Kt/V levels.
When Kt/V is below target, systematic evaluation should address: (1) treatment time compliance, (2) blood flow rate (target Qb ≥ 400 mL/min), (3) dialyzer choice (high-flux, appropriate size), (4) needle gauge (15G preferred), (5) access function (check for stenosis if flows are low), and (6) sampling technique errors. Increasing treatment time by 30 minutes typically adds 0.1-0.2 to spKt/V and is often the most effective intervention.
KDOQI (2015) recommends a minimum spKt/V of 1.2 per session for thrice-weekly HD. The target should be 1.4 to provide a margin above minimum. Values below 1.0 indicate significant underdialysis associated with increased mortality.
Stopping the blood pump causes urea rebound within minutes as urea equilibrates from tissues into blood. The slow-flow technique (reducing Qb to 50-100 mL/min for 15 seconds, then sampling) minimizes this artifact while avoiding overestimation of clearance.
spKt/V (single-pool) treats the body as one compartment. eKt/V (equilibrated) accounts for the dual-compartment distribution of urea and the rebound that occurs after treatment. eKt/V is typically 0.15-0.2 lower than spKt/V and more accurately reflects true clearance.
Not necessarily beyond 1.4-1.6. The landmark HEMO study found no significant mortality benefit from high-dose (spKt/V 1.65) vs. standard-dose (spKt/V 1.25) dialysis. However, longer treatment times improve outcomes independent of Kt/V through better volume control and middle-molecule clearance.
Many dialysis patients retain some native kidney function (residual renal function or RRF). Even 2-3 mL/min of residual urea clearance significantly improves outcomes and reduces the dialysis dose needed. RRF should be preserved by avoiding nephrotoxins and excess ultrafiltration.
PD uses weekly Kt/V (target ≥ 1.7 per KDOQI). Because PD is continuous and low-efficiency, single-pool corrections are not needed. PD Kt/V includes both peritoneal clearance and residual renal function, and is measured from 24-hour dialysate and urine collections.